116 related articles for article (PubMed ID: 1749301)
1. Interphase cell death as related to the cell cycle of melphalan-treated human myeloma cells.
Fernberg JO; Lewensohn R; Skog S
Med Oncol Tumor Pharmacother; 1991; 8(2):63-7. PubMed ID: 1749301
[TBL] [Abstract][Full Text] [Related]
2. Interaction of melphalan and dexamethasone in a human myeloma cell line.
Fernberg JO; Lewensohn R; Skog S
Anticancer Drugs; 1991 Dec; 2(6):565-70. PubMed ID: 1806033
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226.
Fernberg JO; Lewensohn R; Skog S
Eur J Haematol; 1991 Sep; 47(3):161-7. PubMed ID: 1915798
[TBL] [Abstract][Full Text] [Related]
4. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells.
MacLeod CL; Luk A; Castagnola J; Cronin M; Mendelsohn J
J Cell Physiol; 1986 Apr; 127(1):175-82. PubMed ID: 3007537
[TBL] [Abstract][Full Text] [Related]
5. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
Leung BS; Potter AH
J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
[TBL] [Abstract][Full Text] [Related]
6. Interpreting cell cycle effects of drugs: the case of melphalan.
Lupi M; Cappella P; Matera G; Natoli C; Ubezio P
Cancer Chemother Pharmacol; 2006 Apr; 57(4):443-57. PubMed ID: 16195878
[TBL] [Abstract][Full Text] [Related]
7. Effect of melphalan and hyperthermia on cell cycle progression and cyclin B1 expression in human melanoma cells.
Orlandi L; Zaffaroni N; Bearzatto A; Costa A; Supino R; Vaglini M; Silvestrini R
Cell Prolif; 1995 Nov; 28(11):617-30. PubMed ID: 8555374
[TBL] [Abstract][Full Text] [Related]
8. PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R.
Xiong T; Wei H; Chen X; Xiao H
Int J Oncol; 2015 Jan; 46(1):223-32. PubMed ID: 25351371
[TBL] [Abstract][Full Text] [Related]
9. The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cells.
Yamagishi T; Nakaike S; Nanaumi K; Otomo S; Tsukagoshi S
Cancer Chemother Pharmacol; 1993; 32(4):249-54. PubMed ID: 8324865
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
Erba E; Mascellani E; Pifferi A; D'Incalci M
Int J Cancer; 1995 Jul; 62(2):170-5. PubMed ID: 7622292
[TBL] [Abstract][Full Text] [Related]
11. Melphalan resistance in myeloma.
Hall A; Proctor SJ; Harris AL
Br J Haematol; 1986 May; 63(1):1-6. PubMed ID: 3707856
[No Abstract] [Full Text] [Related]
12. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe.
Cives M; Ciavarella S; Rizzo FM; De Matteo M; Dammacco F; Silvestris F
Cell Signal; 2013 May; 25(5):1108-17. PubMed ID: 23380051
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
14. Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis-diamminedichloroplatinum induces a block in G2/M.
Shinomiya N; Takemura T; Iwamoto K; Rokutanda M
Cytometry; 1997 Apr; 27(4):365-73. PubMed ID: 9098629
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle arrest by prostaglandin A1 at the G1/S phase interface with up-regulation of oncogenes in S-49 cyc- cells.
Hughes-Fulford M
J Cell Biochem; 1994 Mar; 54(3):265-72. PubMed ID: 8200906
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma.
Millar BC; Bell JB; Maitland JA; Zuiable A; Gore ME; Selby PJ; McElwain TJ
Br J Haematol; 1989 Feb; 71(2):213-22. PubMed ID: 2923807
[TBL] [Abstract][Full Text] [Related]
17. The action of epidermal growth factor (EGF) is limited to specific phases of the cell cycle in an EGF dependent colonic cell line.
Sizeland A; Bol S; Burgess AW
Growth Factors; 1991; 4(2):129-43. PubMed ID: 2049180
[TBL] [Abstract][Full Text] [Related]
18. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
Braunagel SC; Parr R; Belyavskyi M; Summers MD
Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitivity of human small cell carcinoma of the lung detected by flow cytometric DNA analysis of drug-induced cell cycle perturbations in vitro.
Engelholm SA; Spang-Thomsen M; Vindeløv LL; Brünner NA
Cytometry; 1986 May; 7(3):243-50. PubMed ID: 3011370
[TBL] [Abstract][Full Text] [Related]
20. Alteration of cell cycle progression in human leukemia cell line (KOPM-28) induced by 12-o-tetradecanoylphorbol-13-acetate.
Tsuda H; Sakaguchi M; Kawakita M; Nakazawa S; Mori T; Takatsuki K
Int J Cell Cloning; 1988 May; 6(3):209-20. PubMed ID: 3397593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
